Advertisement

Topics

Axcan Pharma™ Company Profile

08:14 EDT 25th June 2018 | BioPortfolio

Axcan develops, manufactures, markets and distributes gastroenterology products and therapeutic treatments worldwide, while focusing primarily in North America and the European Union. Click on the Axcan Worldwide image below to view products and services information specific to the United States, Canada, and France.

Location

22 Inverness Center Parkway
Birmingham
Alabama
35242
United States of America

Contact

Phone: (205) 991-8085
Fax: (205) 991-8176
Email: iadjahi@axcan.com


News Articles [738 Associated News Articles listed on BioPortfolio]

CR Pharma to Acquire Jiangzhong Pharma for $667 Million

China Resources Pharma will pay $667 million to acquire all the outstanding shares of Jiangzhong Pharma, a listed company. Three weeks ago, CR Pharma announced plans to acquire a stake in the parent c...

#jobs #lifescience Accountant – Biotech / Pharma (Up to $70K)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Accountant – Biotech / Pharma (Up to $70K) .MA-Boston, Publicly Traded ...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Verona Pharma plc: Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...

Verona Pharma plc: Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017

LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative...

Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Completes Acquisition of Remaining 20% Interest in PhytoPain Pharma Inc.

OTTAWA, ONTARIO -- (Marketwired) -- 03/19/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced the completion of the previously announced acq...

Verona Pharma plc: Verona Pharma Provides Clinical Development Update

Accelerates top-line data readouts from ongoing clinical trials with RPL554 in COPD and CFLONDON, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a cli...

Why pharma engagement on twitter matters!

The fact that thousands of stakeholders chose to follow pharma accounts on twitter deserves our attention. It says that there are people out there genuinely interested in what pharma has ...

Drugs and Medications [252 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

Moving pharma contracting into the era of accountability.

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Rejuvenating the Face: An Analysis of 100 Absorbable Suture Suspension Patients.

Absorbable suture suspension (Silhouette InstaLift, Sinclair Pharma, Irvine, CA) is a novel, minimally invasive system that utilizes a specially manufactured synthetic suture to help address the issue...

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

A totally new system is needed for drug research and development.

In response to my paper, where I call for abolishment of patents and for drug research and development as a public enterprise, Raj asserts that there is an increase in novel drug discoveries. The fact...

Clinical Trials [79 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [748 Associated Companies listed on BioPortfolio]

Axcan Pharma™

Axcan develops, manufactures, markets and distributes gastroenterology products and therapeutic treatments worldwide, while focusing primarily in North America and the European Union. Click on the Axc...

Axcan Pharma Incorporated

Axcan is a leading specialty pharmaceutical company within the field of gastroenterology in North America and Europe. Axcan markets a broad line of pharmaceutical products used in the treatment of a v...

Axcan Pharmaceuticals Incorporated

Axcan is a leading specialty pharmaceutical company within the field of gastroenterology in North America and Europe. Axcan markets a broad line of pharmaceutical products used in the treatment of a v...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "Axcan Pharma™" on BioPortfolio

We have published hundreds of Axcan Pharma™ news stories on BioPortfolio along with dozens of Axcan Pharma™ Clinical Trials and PubMed Articles about Axcan Pharma™ for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axcan Pharma™ Companies in our database. You can also find out about relevant Axcan Pharma™ Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record